期刊文献+

酒精性肝炎144例临床分析

Clinical analysis of 144 Cases Alcoholic Hepatitis
下载PDF
导出
摘要 目的观察酒精性肝炎的临床表现、治疗及预后。方法对144例酒精性肝炎患者的临床资料进行回顾性分析研究。结果 144例酒精性肝炎患者,安验室检查均无病毒性肝炎史,血清肝炎病毒标志物检查亦阴性。经对症治疗后显效80例,有效50例,总有效率为90.28%;转为肝硬化者12例,死亡2例。结论长期大最饮酒是引起酒精性肝病的主要原因,每天饮酒100 g以上,持续5年以上,90%有脂肪肝,10%~35%有酒精性肝炎,1.5%~8%有酒精性肝硬化。严格戒酒是其良好预后的关键。 Objective To explore the cause of disease,therapy effect and prognosis of the alcoholic hepatitis. Methods Sufferor's clinical data of 144 cases alcoholic hepatitis was retrospective analysis research. Results Among the 144 patients,80 cases show effect,50 cases were valid,total efficient rate were 90. 28%. 12 cases turn into the cirrhosis,2 case died. Conclusion Longterm great deal of drinking alcohol is the main reason of alcoholic hepatitis. Drinking everyday 100 g for5 years above,90% patients suffered from the fatty liver, 10% ~ 35% patients suffered from the alcoholic hepatitis. 1.5% -8% suffered from the alcoholic cirrhosis. Abstain from alcohol strictly is the key for good prognosis.
作者 兰克军
出处 《中国医学创新》 CAS 2011年第15期157-158,共2页 Medical Innovation of China
关键词 酒精性肝炎 肝硬化 Alcoholichepatitis Cirrhosis
  • 相关文献

参考文献6

二级参考文献25

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 2姚桢 见:江正辉 王泰龄主编.酒精性肝病的发病机制:遗传学机制[A].见:江正辉,王泰龄主编.酒精性肝病[C].北京:中国医药科技出版社,2001.20~21.
  • 3Checa JF, Bellentani S, Tiribelli C. Alcohol-induced liver disease: From molecular damage to treatment. Rev Med Chile, 2002, 130: 681-690.
  • 4Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology, 2003, 37: 493-503.
  • 5Monzoni A, Masutti F, Saccoccio G, Bellentani S,Tiribelli C, Giacca M. Genetic determinants of ethanol-induced liver damage. Mol Med, 2001, 7:255 -262.
  • 6Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology, 1997, 26: 143-146.
  • 7Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med, 2001, 7: 408-413.
  • 8Grove J, Daly AK, Bassendine MF, Gilvarry E,Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut, 2000, 46: 540-545.
  • 9Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology, 2001, 33: 1148-1153.
  • 10Starkel P, Bishop K, Horsmans Y, Strain AJ. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. Am J Pathol, 2003,162: 587-596.

共引文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部